MRI

Breast MRI and the double standards of evidence-based medicine

At EUSOBI 2026, Prof. Christiane Kuhl delivered a pointed critique of the evidence behind breast imaging guidelines. Drawing on decades of research, she questioned why breast MRI faces barriers to clinical adoption while other imaging methods appear to be judged by different standards.

Brainomix AI Analysis Finds Treatment Signals in CHARM Stroke Trial

Post-hoc analysis of Phase 3 CHARM data suggests NCCT-based infarct volume assessment could help identify patients who may respond to investigational CIRARA.

Smarter, Deeper, Greener: How MRI Is Evolving

New MRI research explores 10.5T coil design, tumor oxygenation, electrical conductivity imaging and energy consumption to advance imaging capabilities and efficiency.

Paradromics and Siemens Healthineers Collaborate on BCI Imaging

Paradromics and Siemens Healthineers are developing an imaging workflow combining MRI, functional imaging and CT to support BCI implantation and follow-up.

PSMA PET/CT improves prostate cancer detection

A prospective study found PSMA PET/CT-targeted biopsy detected more clinically significant prostate cancer than systematic biopsy in men with nondiagnostic MRI.

Optimizing Energy Use in CT and MRI

Energy savings in CT and MRI can come from low-power modes, protocol optimization, and better measurement, with medical physicists helping integrate changes into clinical workflows.

Midea Completes Acquisition of Esaote

Midea Group has expanded its presence in the medical technology sector with the acquisition of a controlling stake in Italian medical imaging company Esaote, bringing the company into its Healthcare Division.

Results from Minibeam Radiotherapy Study in Resistant Cancers

Mayo Clinic researchers report symptom improvement and tumor responses in a study of minibeam radiotherapy for treatment-resistant skin and soft tissue cancers.

MBI in Dense Breasts: Stronger Evidence for Supplemental Screening

New multicenter data presented at AAPM 2026 strengthen the evidence for molecular breast imaging as a supplemental screening tool in women with dense breasts.

SORDINO MRI Method Reduces Noise and Distortion in Brain Research

Researchers at the University of North Carolina develop SORDINO, an fMRI method that reduces acoustic noise and electromagnetic interference in mouse studies.

FAP-targeted PET/MRI Shows Higher Endometriosis Detection in Difficult-to-assess Areas

A retrospective study found FAP-targeted PET/MRI identified more endometriosis-suspicious findings than MRI alone, including difficult-to-assess areas.

Digital Humans Could Bring More Clinical Realism Into Simulation

Medical simulation is getting better at reproducing scanners. The next challenge is reproducing the patient.

UW Health Kids Opens First Pediatric Interventional Radiology Suite

GE HealthCare's Allia Moveo Powers New Facility in Madison, Wisconsin

As Active Implants Evolve, So Must MRI Safety

Advances in implant technology are expanding MRI access while demanding more sophisticated approaches to safety and clinical decision-making.

Imagion Biosystems and Siemens Healthineers Extend Collaboration

Imagion Biosystems has extended its collaboration with Siemens Healthineers to support the Phase 2 clinical trial of the MagSense imaging agent for HER2-positive breast cancer.

Remote MR scanning moves toward governance, not just convenience

As remote MR expands, experts argue that governance must evolve alongside the technology.

Quibim brings AI-powered breast MRI cancer detection to Europe

Quibim has launched QP-Breast, Europe's first CE- and UKCA-marked AI tool for detecting breast cancer on MRI, helping radiologists improve diagnostic efficiency.

FDA Approves Bayer’s Low-Dose MRI Contrast Agent Ambelvist in the U.S.

Bayer has announced FDA approval of Ambelvist (gadoquatrane), a low-dose macrocyclic gadolinium-based contrast agent for contrast-enhanced MRI.

Athens-Limestone Expands MRI Access for Patients with Cardiac Devices

Athens-Limestone Hospital has expanded MRI access for patients with pacemakers and implantable defibrillators through remote programming technology.

Study Highlights Ongoing MRI Safety Risks in Pediatric Imaging

A new multi-center study published in JACR found that MRI safety incidents in pediatric imaging departments remain relatively uncommon but continue to pose risks for patients and staff.

GE HealthCare Highlights AI-Powered MRI Technologies at ISMRM 2026

At ISMRM 2026, GE HealthCare is presenting new MRI technologies and research tools focused on AI-driven workflows, deep-learning reconstruction, helium-free MRI systems, and collaborative neuroscience research.

Esaote updates low-field open iMRI concept “I-Genius” for repeat MRI checks during glioma surgery

Esaote has presented the latest developments of I-Genius, an open intraoperative MRI (iMRI) concept intended to enable multiple MRI acquisitions during glioma surgery.

SimonMed Expands AI-Enhanced MRI with SwiftMR Deployment

SimonMed has deployed AIRS Medical’s AI-powered SwiftMR solution across its nationwide imaging network to improve MRI image quality, reduce scan times, and support workflow efficiency across a multi-vendor MRI infrastructure.

Combined OCT and MRI Improve Diagnosis of MINOCA

A dual imaging approach combining OCT and cardiac MRI identified the underlying cause in 79% of patients with myocardial infarction and non-obstructive coronary arteries (MINOCA).

MRI Combination Marker Shows High Accuracy in Cervical Cancer Grading

Combining diffusion MRI parameters with macromolecular proton fraction (MPF) achieved a 96% AUC in differentiating low- and high-grade cervical cancer.

Premier Radiology Expands Teleradiology with GLOBIS Acquisition

The acquisition is intended to strengthen diagnostic imaging coverage and support growing demand for outpatient imaging services.

Japan Approves Low-Dose MRI Contrast Agent Ambelvist

Bayer has received the first global approval for its low-dose MRI contrast agent Ambelvist™ (gadoquatrane) in Japan.

Bracco at ECR: AI, contrast agents and new paths to more precise imaging

Bracco Imaging showcased AiMIFY® at ECR, an AI-powered MRI contrast enhancement solution developed with Subtle Medical that analyzes brain scans and amplifies existing contrast signals.

UChicago Medicine Expands Neurosurgery With Intraoperative MRI

UChicago Medicine has introduced intraoperative MRI technology to support complex neurosurgical procedures, enabling real-time imaging during surgery and enhancing precision, safety, and workflow efficiency.

Siemens Healthineers Showcases Imaging Innovations at RSNA 2025

New systems aim to improve lesion visibility, workflow efficiency, and interventional imaging capabilities

Esaote Unveiled New Ultrasound Systems and AI Imaging Tools at ECR 2026

Italian imaging specialist introduced new ultrasound platforms for interventional radiology alongside AI-powered MRI and enterprise imaging innovations.

Bayer Presents New Data for Contrast Agent Gadoquatrane from Phase III Program at ECR 2026

New analyses show Bayer’s investigational MRI contrast agent delivers non-inferior diagnostic performance while reducing gadolinium dose by 60%.

Prof. Minerva Becker on Imaging, AI and the Vision Behind ECR 2026

In our interview, ECR 2026 President Prof. Minerva Becker shares her vision for “Rays of Knowledge,” education, AI and the future of imaging.

Bayer Presents Phase III Cardiac MRI Data for Low-Dose Gadoquatrane

Bayer has reported positive Phase III subgroup data for its investigational low-dose MRI contrast agent gadoquatrane in cardiac MRI. The results, presented at SCMR 2026, support efficacy and safety with a 60% reduction in gadolinium dose compared to standard macrocyclic agents.

Imaging risks for the most vulnerable patients

Possibilities to improve imaging and reduce exposure

Guerbet Highlights Centenary and Imaging Portfolio at ECR 2026

At ECR 2026 in Vienna, Guerbet will mark its 100th anniversary while presenting developments across contrast-enhanced MRI, real-world evidence, and international collaboration

Bayer to Present Phase III Gadoquatrane Data at ECR 2026

Bayer will present new Phase III clinical data for its investigational low-dose MRI contrast agent gadoquatrane at ECR 2026 in Vienna.

NHS Fife Cuts MRI Scan Times Over 20% With Siemens AI

NHS Fife has implemented Siemens Healthineers’ Deep Resolve technology to shorten MRI scan times by more than 20%. The AI-based image reconstruction approach has reduced waiting times, and enabled nearly 1,900 additional MRI appointments within six months.

MRI Connectivity Patterns May Help Predict TBI Recovery

New research suggests that resting-state functional MRI performed shortly after traumatic brain injury may help predict long-term recovery. Specific brain connectivity patterns were found to be associated with functional outcomes six months after injury.

ASE Reviews 2025 Advocacy Priorities in Cardiovascular Imaging

The American Society of Echocardiography (ASE) has reviewed its healthcare advocacy activities in 2025, highlighting efforts related to Medicare reimbursement, workforce shortages, artificial intelligence policy, and federal research funding in cardiovascular imaging.

ESR Welcomes EU Safe Hearts Plan for Cardiovascular Health

The European Society of Radiology (ESR) has welcomed the European Commission’s Safe Hearts Plan, a new EU-wide strategy to address cardiovascular health in Europe.

Bayer Reports Positive Pediatric Data for Low-Dose MRI Contrast Agent Gadoquatrane

Bayer has released late-breaking results from the QUANTI Pediatric study, showing that its investigational low-dose MRI contrast agent gadoquatrane met all primary and secondary endpoints in children.

Expanding Evidence in Pediatric MRI: Bayer Highlights at RSNA

Advancing patient-centered imaging through pediatric data, contrast innovation, and cross-disciplinary collaboration

RSNA 2025: Imaging the Hidden Language of the Brain

A session highlighting how amyloid, tau, and FDG PET sharpen Alzheimer’s diagnosis, support therapy decisions, and improve safety monitoring, marking a key advance in precision imaging.

Innovating Cancer Care: Bayer’s Low-Dose Contrast Enhanced MRI

Advancing radiology for smart imaging

Circular MRI Model Could Save Hospitals Over $500K Per Scanner

Adopting circular business models for MRI systems could reduce total ownership costs by up to 21% and cut emissions and material use significantly.

Transforming Prostate Care: Innovation and Progress through Partnership in Radiology

Two leading voices discuss how collaboration drives progress in oncologic imaging.

Digital Twins in Radiology: Your Key Questions Answered

Learn what digital twins mean for CT and MRI – from workflow optimization to ROI – in this industry-focused radiology FAQ.

Radiology Staffing Shortages: U.S. vs. UK Approaches

High vacancy rates continue to affect imaging departments. Data highlights the scale of the workforce shortage and measures to address the challenge.

FDA Grants Clearance for DeepHealth’s TechLive™

DeepHealth has received FDA 510(k) clearance for TechLive™, a vendor-agnostic remote scanning solution.